United States (US) Drug Screening Market (2025-2031) | Competitive Landscape, Trends, Analysis, Value, Companies, Industry, Outlook, Forecast, Segmentation, Growth, Share, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Drug Screening Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Drug Screening Market - Industry Life Cycle

3.4 United States (US) Drug Screening Market - Porter's Five Forces

3.5 United States (US) Drug Screening Market Revenues & Volume Share, By Product & Service, 2021 & 2031F

3.6 United States (US) Drug Screening Market Revenues & Volume Share, By Sample Type, 2021 & 2031F

3.7 United States (US) Drug Screening Market Revenues & Volume Share, By End User, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing awareness about drug abuse and its impact on workplace productivity and safety

4.2.2 Stringent regulations mandating drug testing in various industries such as transportation, healthcare, and government

4.2.3 Rise in drug-related accidents and fatalities leading to the need for effective screening methods

4.3 Market Restraints

4.3.1 High costs associated with implementing drug testing programs

4.3.2 Concerns about invasion of privacy and potential discrimination related to drug testing

4.3.3 Availability of alternative solutions such as synthetic urine and detox products that can bypass drug screening tests

6.1 United States (US) Drug Screening Market, By Product & Service

6.1.1 Overview and Analysis

6.1.2 United States (US) Drug Screening Market Revenues & Volume, By Product & Service, 2021- 2031F

6.1.3 United States (US) Drug Screening Market Revenues & Volume, By Equipment, 2021- 2031F

6.1.4 United States (US) Drug Screening Market Revenues & Volume, By Rapid Testing Devices, 2021- 2031F

6.1.5 United States (US) Drug Screening Market Revenues & Volume, By Consumables, 2021- 2031F

6.1.6 United States (US) Drug Screening Market Revenues & Volume, By Laboratory Services, 2021- 2031F

6.2 United States (US) Drug Screening Market, By Sample Type

6.2.1 Overview and Analysis

6.2.2 United States (US) Drug Screening Market Revenues & Volume, By Urine Sample, 2021- 2031F

6.2.3 United States (US) Drug Screening Market Revenues & Volume, By Breath Sample, 2021- 2031F

6.2.4 United States (US) Drug Screening Market Revenues & Volume, By Oral Fluid Sample, 2021- 2031F

6.2.5 United States (US) Drug Screening Market Revenues & Volume, By Hair Sample, 2021- 2031F

6.2.6 United States (US) Drug Screening Market Revenues & Volume, By Others, 2021- 2031F

6.3 United States (US) Drug Screening Market, By End User

6.3.1 Overview and Analysis

6.3.2 United States (US) Drug Screening Market Revenues & Volume, By Workplace and Schools, 2021- 2031F

6.3.3 United States (US) Drug Screening Market Revenues & Volume, By Drug Testing Laboratories, 2021- 2031F

6.3.4 United States (US) Drug Screening Market Revenues & Volume, By Criminal Justice System & Law Enforcement Agencies, 2021- 2031F

6.3.5 United States (US) Drug Screening Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.6 United States (US) Drug Screening Market Revenues & Volume, By Drug Treatment Centers, 2021- 2031F

6.3.7 United States (US) Drug Screening Market Revenues & Volume, By Pain Management Centers, 2021- 2031F

7.1 United States (US) Drug Screening Market Export to Major Countries

7.2 United States (US) Drug Screening Market Imports from Major Countries

8.1 Percentage increase in the number of workplace drug testing programs implemented annually

8.2 Adoption rate of advanced drug screening technologies such as oral fluid testing and hair follicle testing

8.3 Number of drug-related incidents reported in workplaces despite drug testing programs in place

9.1 United States (US) Drug Screening Market Opportunity Assessment, By Product & Service, 2021 & 2031F

9.2 United States (US) Drug Screening Market Opportunity Assessment, By Sample Type, 2021 & 2031F

9.3 United States (US) Drug Screening Market Opportunity Assessment, By End User, 2021 & 2031F

10.1 United States (US) Drug Screening Market Revenue Share, By Companies, 2024

10.2 United States (US) Drug Screening Market Competitive Benchmarking, By Operating and Technical Parameters